Veterinary Cardiology Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Veterinary cardiology focuses on the diagnosis, monitoring, and treatment of cardiovascular diseases in animals, spanning devices such as electrocardiographs, echocardiographs, Holter monitors, and cardiac medications. The market encompasses diagnostics, therapeutics, and monitoring solutions primarily targeted at companion animals, dogs and cats, as well as equine and livestock species. Publicly available industry data from multiple market research organizations consistently place the 2025 global market size in the $2.83 billion to $3.19 billion range, with the middle estimate centering near $2.98 billion.

• •Market valued at approximately $2.98 billion in 2025, with slight variation across research estimates
• •Projected growth to $4.46-$6.1 billion by 2030-2034 depending on forecast scope
• •Encompasses diagnostics, therapeutics, and monitoring equipment for animal cardiac care

The increasing humanization of pets has led owners to seek more advanced veterinary medical interventions, including specialized cardiology care. Approximately one in ten dogs develops heart disease, with prevalence rising sharply after age seven, creating sustained demand for diagnostic and therapeutic solutions. Advances in veterinary medicine have extended the lifespan of companion animals, increasing the population of geriatric pets at higher risk for cardiovascular conditions.

• •Approximately 10% of dogs develop heart disease, with incidence increasing significantly with age
• •Rising pet insurance coverage reduces out-of-pocket costs for owners and enables acceptance of advanced cardiology procedures
• •Technological convergence with human medical devices enables more sophisticated veterinary cardiac diagnostics and treatments

The market is commonly segmented by product type, including diagnostic imaging systems, electrocardiography devices, cardiac medications, and monitoring equipment, and by animal type, with companion animals representing the dominant segment. Geographically, North America holds the largest market share due to high pet ownership rates, strong veterinary infrastructure, and widespread adoption of advanced medical technologies. Europe and Asia-Pacific are the next-largest markets, with Asia-Pacific expected to grow at the fastest pace as veterinary healthcare systems develop in countries such as China, Japan, and India.

• •North America leads the market, supported by high companion animal populations and advanced veterinary infrastructure
• •Asia-Pacific is the fastest-growing regional market, driven by rising pet ownership and expanding veterinary healthcare access
• •Diagnostics segment specifically projected to grow at 8.6% CAGR from 2025 to 2030

What are the recent trends and outlook?

The market outlook remains strongly positive through the early 2030s, with consensus forecasts pointing to continued expansion at or above 8% annually. Key trends include the growing adoption of telemedicine and remote cardiac monitoring for pets, increased availability of minimally invasive interventional cardiology procedures, and rising awareness of breed-specific cardiac predispositions among veterinary practitioners. Advances in veterinary pharmacology, including novel positive inotropes and anti-arrhythmic agents, are expected to further expand treatment options.

• •Remote cardiac monitoring and wearable pet health devices are emerging as significant growth opportunities
• •North America is expected to retain dominant market share throughout the forecast period
• •Increasing awareness of breed-specific cardiac diseases is driving earlier diagnosis and intervention in veterinary practice